A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
Summary
- Eligibility
- for people ages 12 years and up (full criteria)
- Location
- at San Francisco, California
- Dates
- study startedcompletion around
- Principal Investigator
- by Sue S Yom, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Lead Scientist at UCSF
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Coherus Biosciences, Inc.
- ID
- NCT06457503
- Phase
- Phase 4 Nasopharyngeal Cancer Research Study
- Study Type
- Interventional
- Participants
- Expecting 100 study participants
- Last Updated